The Efficacy of Deferring BCG Vaccination to 14 Weeks of Age in HIV-1 Exposed Infants in Uganda

Conditions:   Lower Respiratory Tract Infections;   Septicaemia;   Diarrhoea;   MalariaInterventions:   Biological: Delayed BCG;   Biological: Control arm: BCG at birthSponsors:   Makerere University;   Centre For International Health;   Radboud UniversityNot yet recruiting - verified November 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials